Skip to main content
. Author manuscript; available in PMC: 2014 Jul 22.
Published in final edited form as: Breast Cancer Res Treat. 2013 Mar 8;138(2):415–425. doi: 10.1007/s10549-013-2465-6

Fig. 1.

Fig. 1

Functional inactivation of p53 immortalizes WT and αB-crystallin−/− KO MEFs. a Immunoblot analysis of WT and αB-crystallin−/− KO MEFs. Human mammary epithelial cells (HMEC) were used as a positive control. b WT and αB-crystallin−/− KO MEFs stably expressing a dominant negative (DN) p53 cDNA or vector control were analyzed by immunoblotting. c WT and αB-crystallin−/−KO MEFs stably expressing empty vector or DN were stained for senescence-associated β-galactosidase activity. The percentage of β-galactosidase positive cells was scored (mean ± SD, n = 3). ***P < 0.001 versus vector controls